GUIDE-IN-TMS: MRI guided depression treatment planning for individualized, network-targeted transcranial magnetic stimulation

Description of the granted funding

Major depression disorder is the third leading cause of disability worldwide, and one out of fifteen people in the developed world suffer from it. Unfortunately, half of these people do not respond to antidepressants. There is therefore an urgent need for effective and well-tolerated alternative treatments for depression. One such promising technique is transcranial magnetic stimulation (TMS), which has been used in hospitals for several years. The efficacy of TMS is, however, currently limited. The goal of this project is to develop TMS into a highly effective depression treatment approach. To achieve this, we will make personalized treatment plans using new magnetic resonance imaging techniques, which we will develop in this project. We expect that this project can lead to a breakthrough in depression treatment. In the long term, our approach can serve as a blueprint to develop new personalized TMS treatments for other brain disorders as well.
Show more

Starting year

2022

End year

2027

Granted funding

Dogu Baran Aydogan Orcid -palvelun logo
447 650 €

Related funding decisions

368476
Research costs of Academy Research Fellows(2025)
156 207 €
353798
Research costs of Academy Research Fellows(2022)
240 000 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Decision maker

Scientific Council for Natural Sciences and Engineering
12.05.2022

Other information

Funding decision number

348631

Fields of science

Neurosciences

Research fields

Neurotiede

Identified topics

brain, neuroscience